darolutamide,apalutamide,Enzalutamide
janssen,pfizer,Astellas
['apa ', 'crpc', ' daro ']
dear: rwe of daro, enza &amp; apa for pts w/ nmcrpc in improved outcomes w/ daro: % discont ari: 30.4% daro vs 40.8% enza/46.0% apa % prog to mets: 17.7% daro vs 28.3% enza/27.8% apa % aes: 24.9% daro vs 29.3% enza/30.2% apa #asco23 
Uro Onc @GACancerCenter | Assoc Prof, Resident PD, and Ronald W. Lewis, MD Chair of Uro Educ @mcg_urology | #mentalhealth research | @urotoday Contributor